A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Zinc
Sarilumab
The risk or severity of adverse effects can be increased when Sarilumab is combined with Hydrocortisone acetate.
Zinc
Peficitinib
The risk or severity of adverse effects can be increased when Peficitinib is combined with Hydrocortisone acetate.
Zinc
Voclosporin
The risk or severity of adverse effects can be increased when Voclosporin is combined with Hydrocortisone acetate.
Zinc
Pirarubicin
The risk or severity of adverse effects can be increased when Pirarubicin is combined with Hydrocortisone acetate.
Zinc
Ravulizumab
The risk or severity of adverse effects can be increased when Ravulizumab is combined with Hydrocortisone acetate.
Zinc
Ixekizumab
The risk or severity of adverse effects can be increased when Ixekizumab is combined with Hydrocortisone acetate.
Zinc
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Hydrocortisone acetate.
Zinc
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Peginterferon beta-1a is combined with Hydrocortisone acetate.
Zinc
Vilanterol
The risk or severity of adverse effects can be increased when Vilanterol is combined with Hydrocortisone acetate.
Zinc
Dinutuximab
The risk or severity of adverse effects can be increased when Dinutuximab is combined with Hydrocortisone acetate.
Zinc
Blinatumomab
The risk or severity of adverse effects can be increased when Blinatumomab is combined with Hydrocortisone acetate.
Zinc
Vedolizumab
The risk or severity of adverse effects can be increased when Vedolizumab is combined with Hydrocortisone acetate.
Zinc
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Hydrocortisone acetate.
Zinc
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Hydrocortisone acetate.
Zinc
Belimumab
The risk or severity of adverse effects can be increased when Belimumab is combined with Hydrocortisone acetate.
Zinc
Eribulin
The risk or severity of adverse effects can be increased when Eribulin is combined with Hydrocortisone acetate.
Zinc
Wortmannin
The risk or severity of adverse effects can be increased when Wortmannin is combined with Hydrocortisone acetate.
Zinc
Bendamustine
The risk or severity of adverse effects can be increased when Bendamustine is combined with Hydrocortisone acetate.
Zinc
Belatacept
The risk or severity of adverse effects can be increased when Belatacept is combined with Hydrocortisone acetate.
Zinc
Abetimus
The risk or severity of adverse effects can be increased when Abetimus is combined with Hydrocortisone acetate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3